COMMUNIQUÉS West-GlobeNewswire

The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
28/08/2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma [...]
Can-Fite Reports H1 2025 Financial Results and Clinical Update
28/08/2025
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
Oculis to Participate in Upcoming September Investor Conferences
28/08/2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro- [...]
Oculis to Participate in Upcoming September Investor Conferences
28/08/2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro- [...]
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
28/08/2025
TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 [...]
Trading by management and close relations of management
28/08/2025
Please read the announcement in PDF Attachment 2025_41_Trading_By_Management
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
28/08/2025
Allschwil, Switzerland – August 28, 2025 Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – [...]
IBA réalise des résultats solides au premier semestre 2025, évoluant vers une plus haute profitabilité
28/08/2025
Cliquez ici pour lire l'intégralité du communiqué de presse des résultats du premier semestre 2025 Louvain-La-Neuve, Belgique, 28 août 2025 - IBA (Ion Beam Applications S.A.), le leader mondial de la technologie d’ [...]
IBA reports strong Half Year 2025 results, transforming towards a more profitable business
28/08/2025
Read the entire half year 2025 results press release here Louvain-la-Neuve, Belgium, 28 August 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its [...]
argenx to Present at Upcoming Investor Conferences
28/08/2025
August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
International Observers Raise Concerns Over Judicial Irregularities in Senegal; Rights Advocates Stress Importance for Governance and Investment
28/08/2025
Khadim Ba, a Non-Executive Director at DerMond Oil & Gas LOS ANGELES, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Independent legal experts and rights monitors are raising concerns over the ongoing detention and judicial [...]
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
28/08/2025
- The offering was made to two new fundamental institutional investors - - The Company intends to use the net proceeds to fund preparation for our Phase 3 programs of zervimesine in neurodegenerative disorders - [...]
Quest PharmaTech Announces Results from AGM
27/08/2025
EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders. The Company [...]
Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure
27/08/2025
WARREN, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today updated investors of its significant internally developed assets, which under U.S. GAAP [...]
KFSHRC’s 24/7 Emergency Virtual Clinic Serves Over 23,500 Patients in First Year
27/08/2025
RIYADH, Saudi Arabia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) announced that its 24/7 Emergency Department (ED) Virtual Clinic has delivered more than 23,500 [...]
Cytokinetics to Participate in September Investor Conferences
27/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
27/08/2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Metsera to Present at Upcoming September Investor Conferences
27/08/2025
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic [...]
Bicara Therapeutics to Participate in Upcoming Investor Conferences
27/08/2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]

Pages